Prot #IM047029: A Phase 4, Prospective, Open‐label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice

Project: Research project

Project Details

StatusActive
Effective start/end date9/25/23 → 9/25/26

Funding

  • PPD Investigator Services, LLC (Prot #IM047029 // Prot #IM047029)
  • Celgene International II Sàrl (Prot #IM047029 // Prot #IM047029)